• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

How eClinicalWorks Agentic AI Is Helping Revenue Cycle Leaders Improve Financial Performance
  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • AI
    • Blockchain
    • Precision Medicine
    • Telehealth
    • Wearables
  • Life Sciences
  • Investments
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage

ResApp

ResApp Awarded CE Mark for Smartphone-based Diagnostic Test for Adult Respiratory Disease

by Fred Pennic 09/27/2019 Leave a Comment

ResApp Awarded CE Mark for Smartphone-based Diagnostic Test for Adult Respiratory Disease

- ResApp awarded second CE mark for its first smartphone-based diagnostic test for respiratory disease.- CE Mark certification indicates that ResAppDx-EU version 2 meets the essential requirements of all the applicable European regulations as a class IIa medical device and allows for its sale throughout the European Economic Area.- ResAppDx-EU version 2 is a software-only solution that runs on a smartphone and does not require any additional hardware or accessories.ResApp Health Ltd., the
Read More

ResApp Awarded CE Mark for Smartphone-Based Diagnostic Test for Respiratory Disease

by Fred Pennic 08/23/2019 Leave a Comment

ResApp Awarded CE Mark for Smartphone-Based Diagnostic Test for Respiratory Disease

ResApp Health, the developers of the world’s first smartphone-based diagnostic test for respiratory disease where one simply coughs into the phone and the machine learning-based algorithm diagnoses the underlying respiratory disease, has received CE Mark certification as a Class IIa medical device.Significance of CE Mark CertificationCE Mark certification indicates that ResAppDx-EU meets the essential requirements of all the applicable European regulations as a medical device and allows for the
Read More

ResApp Develops Sound-based Algorithm to Diagnose Sleep Apnea via Smartphone

by Jasmine Pennic 04/12/2018 Leave a Comment

ResApp Develops Sound-based Algorithm to Diagnose Sleep Apnea via Smartphone

ResApp Health, the Australian digital health  startup that has been working on software for smartphones that can diagnose respiratory diseases from the sound signatures of coughs (US clinical trials underway), has announced a new area of development – a diagnostic test to diagnose obstructive sleep apnea (OSA) using a smartphone – simply by leaving the smartphone next to one’s bed to record sounds of the subject while sleeping – and then the algorithms provide a diagnosis (similar AI use to the
Read More

ResApp Licenses New Algorithm to Improve Diagnostic Screening for Childhood Pneumonia

by Jasmine Pennic 04/28/2017 Leave a Comment

ResApp Nabs $12.5M For Smartphone App That Instantly Diagnose Respiratory Diseases

ResApp Health Limited, a digital health startup provider of smartphone apps for respiratory disease diagnosis and management has signed a licensing agreement with UniQuest, the main commercialization company of The University of Queensland. The licensing agreement includes an additional diagnostic toolset of machine-learning algorithms that use a combination of clinical features to screen for childhood pneumonia. Pneumonia is the leading cause of mortality for children below five years of age.
Read More

ResApp Expands Research Collaboration With Mass General for Diagnostic App

by Jasmine Pennic 01/11/2017 Leave a Comment

ResApp Nabs $12.5M For Smartphone App That Instantly Diagnose Respiratory Diseases

ResApp, a Australian-based digital health startup that has developed a smartphone app that can diagnose respiratory diseases based on the sound signatures of the coughs has entered into a two-year expanded research collaboration with Massachusetts General Hospital (MGH). As part of the research collaboration, ResApp and MGH will perform additional analysis of the SMARTCOUGH-C study data, use the SMARTCOUGH-C dataset to investigate the state of respiratory disease clinical practice today and
Read More

ResApp Nabs $12.5M For Smartphone App That Instantly Diagnose Respiratory Diseases

by HITC Staff 04/20/2016 Leave a Comment

ResApp Nabs $12.5M For Smartphone App That Instantly Diagnose Respiratory Diseases

ResApp, a Australian-based digital health startup that has developed a smartphone app that can diagnose respiratory diseases based on the sound signatures of the coughs, announced it has raised $12.5 million in funding. The oversubscribed round was led by Jett Capital Advisors, Empire Capital Partners and CPS Capital Group. The company plans to use the funding to accelerate the FDA approval for its adult diagnostic test and expand US market access beyond telehealth into in-clinic use, including
Read More

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Featured Insights

How eClinicalWorks Agentic AI Is Helping Revenue Cycle Leaders Improve Financial Performance

Most-Read

Innovaccer-CHIME 2030 Survey Reveals AI Will Automate Nearly Two-Thirds of Administrative Work and Do 3x the Work With the Same Staff

Innovaccer-CHIME 2030 Survey Reveals AI Will Automate Nearly Two-Thirds of Administrative Work and Do 3x the Work With the Same Staff

CB Insights’ 2026 Digital Health 50 Reveals How Agentic AI Is Becoming the Clinical Provider and Medication Access Engine

Oura Acquires Counsel Health for $625M: Scaling Continuous Biometrics into On-Demand Medical Care

M&A: Oura Acquires Counsel Health for $625M: Scaling Continuous Biometrics into On-Demand Medical Care

WittKieffer 2026 Healthcare CIO Survey: 82% Sit on Executive Teams, Yet Only 36% Have Formal Succession Plans

WittKieffer 2026 Healthcare CIO Survey: 82% Sit on Executive Teams, Yet Only 36% Have Formal Succession Plans

CVS Rebrands Health Services Segment, Launches Model for Retail Pharmacy Reimbursement

CVS Health Formalizes Tax-Free Split-Off to Carve Out CVS Pharmacy by 2028

SAMHSA and ONC Invest $20M in Behavioral Health IT Initiative

ONC Finalizes HTI-5 Deregulatory Rule to Cut $1.55B in Health IT Compliance and Accelerate FHIR APIs

Redesign Health Merges with Sheba Medical Center’s ARC Global and Agrees to Acquire AVIA

Redesign Health Merges with Sheba Medical Center’s ARC Global and Agrees to Acquire AVIA

Sword Acquires Headspace in All-Cash Deal Worth Up to $300M to Unify Physical and Mental AI Care

M&A: Sword Acquires Headspace in All-Cash Deal Worth Up to $300M to Unify Physical and Mental AI Care

M&A: Francisco Partners to Acquire Weave in $650M Take-Private Deal

M&A: Francisco Partners to Acquire Weave in $650M Take-Private Deal

Epic Launches One-Click Care Everywhere Diagnostic Image Exchange

Epic Launches One-Click Care Everywhere Diagnostic Image Exchange

Secondary Sidebar

Footer

Company

  • About Us
  • 2026 Editorial Calendar
  • Advertise with Us
  • Reprints and Permissions
  • Op-Ed Submission Guidelines
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2026. HIT Consultant Media. All Rights Reserved. Privacy Policy |